- Conditions
- Schizophrenia, Schizoaffective Disorder
- Interventions
- MMFS-202-302, Placebo
- Drug
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Interventions
- NRCT-101SR
- Drug
- Lead sponsor
- Neurocentria, Inc.
- Industry
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 95 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 13
- States / cities
- Anaheim, California • Lakeland, Florida • Maitland, Florida + 10 more
- Conditions
- Alzheimer Disease
- Interventions
- MMFS-205-SR, Placebo
- Dietary Supplement
- Lead sponsor
- Neurocentria, Inc.
- Industry
- Eligibility
- 55 Years to 85 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Anxiety, Depression, Sleep Quality, Cognitive Impairment
- Interventions
- Low Dose MMFS-205-SR, High Dose MMFS-205-SR, Placebo
- Dietary Supplement
- Lead sponsor
- Neurocentria, Inc.
- Industry
- Eligibility
- 60 Years to 85 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Springfield, Missouri
- Conditions
- Attention Deficit/Hyperactivity Disorder, ADHD
- Interventions
- L-Threonic Acid Magnesium Salt (L-TAMS)
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- ADHD
- Interventions
- NRCT-101-SR, Placebo
- Drug
- Lead sponsor
- Neurocentria, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 223 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 9
- States / cities
- Garden Grove, California • Lakeland, Florida • Maitland, Florida + 6 more
- Conditions
- ADHD
- Interventions
- NRCT-101SR, NRCT-202XR
- Drug
- Lead sponsor
- Neurocentria, Inc.
- Industry
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 5
- States / cities
- Maitland, Florida • Decatur, Georgia • Savannah, Georgia + 2 more